CN106831673A - The preparation method of Amiodarone Hydrochloride intermediate 2 butyl 3 (the diiodo- benzoyl of 4 hydroxyl 3,5) benzofuran - Google Patents

The preparation method of Amiodarone Hydrochloride intermediate 2 butyl 3 (the diiodo- benzoyl of 4 hydroxyl 3,5) benzofuran Download PDF

Info

Publication number
CN106831673A
CN106831673A CN201710039161.5A CN201710039161A CN106831673A CN 106831673 A CN106831673 A CN 106831673A CN 201710039161 A CN201710039161 A CN 201710039161A CN 106831673 A CN106831673 A CN 106831673A
Authority
CN
China
Prior art keywords
butyl
benzofuran
diiodo
benzoyl
hydroxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710039161.5A
Other languages
Chinese (zh)
Inventor
刘世领
杨志刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lianyungang Jinshuai Pharmaceutical Chemical Co Ltd
Original Assignee
Lianyungang Jinshuai Pharmaceutical Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lianyungang Jinshuai Pharmaceutical Chemical Co Ltd filed Critical Lianyungang Jinshuai Pharmaceutical Chemical Co Ltd
Priority to CN201710039161.5A priority Critical patent/CN106831673A/en
Publication of CN106831673A publication Critical patent/CN106831673A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms

Abstract

Present invention is disclosed the preparation method of a kind of Amiodarone Hydrochloride intermediate 2 butyl 3 (the diiodo- benzoyl of 4 hydroxyl 3,5) benzofuran, by iodine and 2 butyl 3 (4 (2-hydroxybenzoyl)) benzofurans in molar ratio 1.0~4.0:1 mixing, with solvent room temperature reaction 15~50 hours in the presence of acid binding agent, solvent is C1~6 aliphatic alcohols solvent, and butyl 3 (the diiodo- benzoyl of 4 hydroxyl 3, the 5) benzofuran of Amiodarone Hydrochloride intermediate 2 is obtained.Implement above-mentioned technical proposal of the invention, by raw material selection, proportioning, the selection of acid binding agent and the reasonable control of reaction condition, compared to the manufacturing route of prior art, improve operation ease, product quality stability, and it is suitable to put into large-scale industrial production, increases the production capacity of product.

Description

Amiodarone Hydrochloride intermediate 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzo The preparation method of furans
Technical field
The present invention relates to a kind of preparation method of antiarrhythmic drug intermediate, and in particular in a kind of Amiodarone Hydrochloride The preparation method of mesosome 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzofuran.
Background technology
Amiodarone Hydrochloride (ADHC) is one of antiarrhythmic drug the most frequently used at present, is clinically mainly used in supraventricular And ventricular tachyarrhythmia, various organic heart diseasies, acute coronary syndrome etc. are also used for, can be used as there is symptom Property atrial fibrillation is not complete with left chamber function or first-line treatment medication of chronic heart failure.
Arrhythmia cordis is clinical common disease, and it both can individually occur be occurred together with cardiovascular disease, it might even be possible to Break out and cause sudden death, be always treatment problem clinically.ADHC, Xinluning tablet and procaine are treatment arrhythmia cordis Common drug, but proarrhythmia incidence is different while its anti-arrhythmia, therefore, clinically select relative peace Complete effective antiarrhythmic drug it is critical that.ADHC can reduce generation and the arrhythmic deaths of VA Danger, its arrhythmogenic effect is small, and negative inotropic action is light or nothing, and with anti-ischemic effect, conduction hinders generating chamber in Stagnant, these are all not available for other antiarrhythmic drugs.ADHC turned into AMI with room property tachyarrhythmia, The choice drug that ventricular arythmia, heart failure prevent with arrhythmia cordis, sudden cardiac death after infarct.
2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzofuran is the important centre of Amiodarone Hydrochloride (ADHC) Body.The technical measures of the preparation of the intermediate can be divided into following a few classes:
1. organic base heating response utilized, such as Russ P 2186063, with sodium acetate and sodium acid carbonate as acid binding agent, The operation for flowing back in methyl alcohol carrys out iodo.But high temperature reduces the selectivity of iodo, while reducing reaction yield.
2. with NaOH as acid binding agent, with elemental iodine, 0 degree is reacted United States Patent (USP) US 6103708, the yield of bearing reaction Only 47%.Low yield limits the use of the method.
3. Chinese patent CN1858042 increases iodo efficiency with potassium carbonate as acid binding agent by the method for hydrogen peroxide oxidation, But reaction needs to be carried out under the heating of 80-85 degree, and iodo is selectively bad.
The content of the invention
In view of the defect that above-mentioned prior art is present, the purpose of the present invention is to propose to a kind of Amiodarone Hydrochloride intermediate 2- fourths The preparation method of base -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzofuran, solves the difficulty of Amiodarone Hydrochloride course of industrialization Point.
Above-mentioned purpose of the invention, its technical solution being achieved is:A kind of Amiodarone Hydrochloride intermediate 2- fourths The preparation method of base -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzofuran, it is characterised in that:By iodine and 2- butyl -3- (4- (2-hydroxybenzoyl)) benzofuran in molar ratio 1.0~4.0:1 mixing, with solvent room temperature in the presence of oxidant and acid binding agent Reaction 15~50 hours, solvent is C1~6 aliphatic alcohols solvent, and Amiodarone Hydrochloride intermediate 2- butyl -3- (4- hydroxyls are obtained Base -3,5- diiodo-s benzoyl) benzofuran.
As the further prioritization scheme of above-mentioned technical proposal:Wherein described acid binding agent is potassium carbonate, sodium carbonate, hydroxide Potassium, the one kind in NaOH.
The application implementation of technical solution of the present invention, compared to the manufacturing route of prior art, with following notable Visible effect:By raw material selection, proportioning, the selection of catalyst and the reasonable control of reaction condition, salt acid amide iodine is simplified The production technology of ketone intermediate 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzofuran, improve operation ease, Product quality stability, and be suitable to put into large-scale industrial production, increase the production capacity of product.Reaction is entered at normal temperatures OK, the energy is saved, while compared with 0 DEG C and pyroreaction, iodo selectivity and reaction yield are improved largely, and have Save cost to effect.
Specific embodiment
Below just in conjunction with the embodiments, specific embodiment of the invention is described in further detail, so that the technology of the present invention Scheme is more readily understood, grasps.
Embodiment 1:By 2- butyl -3- (4- (2-hydroxybenzoyl)s) 500 grams of benzofuran (1.7mol), 124 grams of potassium carbonate (0.9mol), 453 grams sumptuous (1.7mol) is put into 5 liters of reaction bulbs, plus 2 kilograms of methyl alcohol, complete molten, the room temperature reaction 50 hours of stirring. PH=1, suction filtration, washing filter cake is adjusted to obtain final product faint yellow 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzo furan with concentrated hydrochloric acid Mutter, be vacuum dried to obtain 811 grams of dry product, yield is 87.3%.Obtained product elementary analysis is as follows:Theoretical value:C, 41.78%; H, 2.95%;I, 46.47%;O, 8.79%;Measured value:C, 41.77%;H, 2.96%;I, 46.50%;O, 8.76%
Embodiment 2:By 2- butyl -3- (4- (2-hydroxybenzoyl)s) 500 grams of benzofuran (1.7mol), 50.4 grams of potassium hydroxide (0.9mol), 1132.5 grams sumptuous (4.25mol) is put into 5 liters of reaction bulbs, plus 2 kg ethanols, and stirring is complete molten, and room temperature reaction 30 is small When.PH=1, suction filtration, washing filter cake is adjusted to obtain final product faint yellow 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzene with concentrated hydrochloric acid And furans, 832 grams of dry product is vacuum dried to obtain, yield is 89.6%.Obtained product elementary analysis is as follows:Theoretical value:C, 41.78%;H, 2.95%;I, 46.47%;O, 8.79%;Measured value:C, 41.79%;H, 2.97%;I, 46.47%;O, 8.75%
Embodiment 3:By 2- butyl -3- (4- (2-hydroxybenzoyl)s) 500 grams of benzofuran (1.7mol), 36 grams of NaOH (0.9mol), 1812 grams sumptuous (6.8mol) is put into 5 liters of reaction bulbs, plus 2 kilograms of propyl alcohol, complete molten, the room temperature reaction 15 hours of stirring. PH=1, suction filtration, washing filter cake is adjusted to obtain final product faint yellow 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzo furan with concentrated hydrochloric acid Mutter, be vacuum dried to obtain 827 grams of dry product, yield is 89.1%.Obtained product elementary analysis is as follows:Theoretical value:C, 41.78%; H, 2.95%;I, 46.47%;O, 8.79%;Measured value:C, 41.78%;H, 2.96%;I, 46.47%;O, 8.78%
Embodiment 4:By 2- butyl -3- (4- (2-hydroxybenzoyl)s) 500 grams of benzofuran (1.7mol), 36 grams of NaOH (0.9mol), 1132.5 grams sumptuous (4.25mol) is put into 5 liters of reaction bulbs, plus 2 kilograms of propyl alcohol, and stirring is complete molten, and room temperature reaction 15 is small When.PH=1, suction filtration, washing filter cake is adjusted to obtain final product faint yellow 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzene with concentrated hydrochloric acid And furans, 829 grams of dry product is vacuum dried to obtain, yield is 89.3%.Obtained product elementary analysis is as follows:Theoretical value:C, 41.78%;H, 2.95%;I, 46.47%;O, 8.79%;Measured value:C, 41.80%;H, 2.94%;I, 46.47%;O, 8.78%
Embodiment 5:By 2- butyl -3- (4- (2-hydroxybenzoyl)s) 500 grams of benzofuran (1.7mol), potassium hydroxide 50.4 Gram, 60 grams of potassium carbonate, 1132.5 grams sumptuous (4.25mol) is put into 5 liters of reaction bulbs, plus 2 kg ethanols, propanol mixture, stirring Quan Rong, room temperature reaction 30 hours.With concentrated hydrochloric acid adjust pH=1, suction filtration, washing filter cake obtain final product faint yellow 2- butyl -3- (4- hydroxyls - 3,5- diiodo- benzoyls) benzofuran, 834 grams of dry product is vacuum dried to obtain, yield is 89.8%.Obtained product elementary analysis is such as Under:Theoretical value:C, 41.78%;H, 2.95%;I, 46.47%;O, 8.79%;Measured value:C, 41.80%;H, 2.94%;I, 46.45%;O, 8.80%
Embodiment 6:By 2- butyl -3- (4- (2-hydroxybenzoyl)s) 500 grams of benzofuran (1.7mol), 25 grams of potassium hydroxide (0.9mol), 1132.5 grams sumptuous (4.25mol) is put into 5 liters of reaction bulbs, plus 2 kg ethanols, and stirring is complete molten, and room temperature reaction 30 is small When.PH=1, suction filtration, washing filter cake is adjusted to obtain final product faint yellow 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzene with concentrated hydrochloric acid And furans, 832 grams of dry product is vacuum dried to obtain, yield is 89.6%.Obtained product elementary analysis is as follows:Theoretical value:C, 41.78%;H, 2.95%;I, 46.47%;O, 8.79%;Measured value:C, 41.80%;H, 2.95%;I, 46.45%;O, 8.79%.

Claims (1)

1. a kind of preparation method of Amiodarone Hydrochloride intermediate 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzofuran, It is characterized in that:By iodine and 2- butyl -3- (4- (2-hydroxybenzoyl)s) benzofuran in molar ratio 1.0~4.0:1 mixing, is tiing up acid With solvent room temperature reaction 15~50 hours in the presence of agent, solvent is C1~6 aliphatic alcohols solvent, is obtained in Amiodarone Hydrochloride Mesosome 2- butyl -3- (4- hydroxyl -3,5- diiodo-s benzoyl) benzofuran, described acid binding agent is potassium carbonate, sodium carbonate, hydrogen-oxygen Change the one kind in potassium, NaOH.
CN201710039161.5A 2017-01-19 2017-01-19 The preparation method of Amiodarone Hydrochloride intermediate 2 butyl 3 (the diiodo- benzoyl of 4 hydroxyl 3,5) benzofuran Pending CN106831673A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710039161.5A CN106831673A (en) 2017-01-19 2017-01-19 The preparation method of Amiodarone Hydrochloride intermediate 2 butyl 3 (the diiodo- benzoyl of 4 hydroxyl 3,5) benzofuran

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710039161.5A CN106831673A (en) 2017-01-19 2017-01-19 The preparation method of Amiodarone Hydrochloride intermediate 2 butyl 3 (the diiodo- benzoyl of 4 hydroxyl 3,5) benzofuran

Publications (1)

Publication Number Publication Date
CN106831673A true CN106831673A (en) 2017-06-13

Family

ID=59124391

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710039161.5A Pending CN106831673A (en) 2017-01-19 2017-01-19 The preparation method of Amiodarone Hydrochloride intermediate 2 butyl 3 (the diiodo- benzoyl of 4 hydroxyl 3,5) benzofuran

Country Status (1)

Country Link
CN (1) CN106831673A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104262304A (en) * 2014-09-12 2015-01-07 杨俊� Synthetic method of amiodarone hydrochloride

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104262304A (en) * 2014-09-12 2015-01-07 杨俊� Synthetic method of amiodarone hydrochloride

Similar Documents

Publication Publication Date Title
TWI781196B (en) Purified 2,5-furandicarboxylic acid pathway products
US20070274897A1 (en) Processes for the preparation of chlorine by gas phase oxidation
CN111377890B (en) Method for producing 2,5-furandicarboxylic acid from 5-hydroxymethylfurfural
WO2011031023A2 (en) Method for producing cyclicised compounds from organic acids having from 4 to 6 carbon atoms
CN107335454B (en) Load type Pd3Preparation and application of Cl cluster catalyst
CN103167906A (en) Catalyst and method for the production of chlorine by gas phase oxidation
US7022824B2 (en) Method for the production of sorbit
CN106632180B (en) The synthetic method of amiodarone impurity G and the application of amiodarone impurity G
CN106831673A (en) The preparation method of Amiodarone Hydrochloride intermediate 2 butyl 3 (the diiodo- benzoyl of 4 hydroxyl 3,5) benzofuran
CN107866245A (en) Catalyst for preparing cis-anhydride by n-butane oxidation and preparation method thereof
CN103769103A (en) Supported nickel catalyst for production of hydrogen peroxide through anthraquinone hydrogenation method, and preparation method thereof
CN103157472B (en) Preparation method for supported catalyst used for preparing cyclopentanol through furfural liquid phase hydrogenation
CN101722019A (en) Catalyst and process for preparing chlorine by gas phase oxidation
CN110290870A (en) The reduction reaction catalyst of 3,4- dihydroxytetrahydrofandn and the manufacturing method of 3,4- dihydroxytetrahydrofandn reduzate
CN102584773B (en) Method for preparing mangiferin aglycone
CN109988131A (en) The preparation method of Amiodarone Hydrochloride
CN109305909B (en) Method for synthesizing acrylic acid by glycerol one-step method
CN108003102A (en) A kind of synthetic method of Ivabradine
CN102180848A (en) Preparation method for novel antiarrhythmic medicament of dronedarone
CN109304164B (en) Catalyst for synthesizing acrylic acid by glycerol one-step method
CN107866248A (en) For catalyst for preparing cis-anhydride by n-butane oxidation and preparation method thereof
CN109304162B (en) Method for producing acrylic acid from glycerol
CN112717926A (en) Catalyst for producing hydrogen peroxide by anthraquinone hydrogenation and preparation method and application thereof
CN107915709B (en) Method for preparing ethylene carbonate from ethylene oxide and carbon dioxide
CN109305908B (en) Method for synthesizing acrylic acid from glycerol

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170613